In the news
See all news
August 13, 2018
An International Multicenter Phase II study in Patients with Non-Hodgkin lymphoma is currently ongoing in 6 countries, including Ukraine that was recently initiated by GCT.
Ukrainian sites were activated and started screening procedures last week, bringing 5 randomized patients and 2 more at screening only a week later!
June 22, 2018
GCT BD team has been enriched and we are happy to announce that Chris Matheus joined us to enhance GCT brand recognition as a global clinical CRO.
“I know Chris for several years now and it is to my great pleasure to welcome him to GCT Team. His expertise is very much valued and professional attitude is fully aligned with ours, therefore, we look forward to working together building new successful relationships within the industry,” comments Dr. Eugene Selivra, Chief Executive Officer of GCT.”
June 04, 2018
GCT has worked closely with the Sponsor on reaching this important milestone and over the past months has secured Regulatory and EC approvals, conducted site initiation visits and managed shipments of required supplies to the sites. We have successfully progressed to the enrollment start on schedule in the two participating countries – Hungary and Poland.